THE COCHRANE COLLABORATION
Cochrane is a global, independent, non-profit network of health researchers and professionals, patients and carers who work together to produce and promote trusted, high-quality health information that improves health and healthcare worldwide. Our mission is to produce accessible, trusted evidence and advocate for its use to deliver better, more equitable health for all.
Financial health, per its FY2024 accounts
The accounts state that the charity reported a net deficit of £128,000 for the year ended 31 December 2024, compared to a surplus in the prior year, driven by increased staffing and strategic investments. Per the trustees' report, free reserves stood at £4,833,000, which is above the stated policy target of three months' operating expenditure (£2,600,000). The trustees confirmed that there are no material uncertainties regarding the charity's ability to continue as a going concern.
What the accounts disclose
In the news
- How to communicate scientific uncertainty: A Lifeology and Cochrane collaboration
- What is an infodemic and how can we prevent it?: a Lifeology and Cochrane collaboration
- Cochrane Collaboration expels co-founder splitting board and prompting walkout
- Cochrane Collaboration Expels Cofounder, Prompts Resignations - the-scientist.com
- Mass resignation guts board of prestigious Cochrane Collaboration
- The Cochrane Collaboration (Published 2013)
- The Cochrane Collaboration’s tool for assessing risk of bias in randomised trials
Leadership, per the charity’s website
- Karla Soares-Weiser — Chief Executive Officer
Structured financials (annual return, FY ending 31/12/2024)
Trustees
- Dr Susan Phillipschair
- Dr Giordano Perez Gaxiola
- Dr Juan Victor Ariel Franco
- Emma Eleanor Beatrice Sinervo
- Nigel Jones
- Professor Gillian Leng
- Professor Joerg Meerpohl
- Professor Tamara Kredo
- Professor Vanessa Jordan-Cole
Income and spending
| Financial year end | Income | Spending |
|---|---|---|
| 31/12/2024 | £10.5m | £10.6m |
| 31/12/2023 | £9.7m | £9.4m |
| 31/12/2022 | £8.9m | £7.9m |
| 31/12/2021 | £7.7m | £9.1m |
| 31/12/2020 | £12.8m | £9.0m |
Common questions
Is THE COCHRANE COLLABORATION financially healthy?
Per its FY2024 accounts: The accounts state that the charity reported a net deficit of £128,000 for the year ended 31 December 2024, compared to a surplus in the prior year, driven by increased staffing and strategic investments. Per the trustees' report, free reserves stood at £4,833,000, which is above the stated policy target of three months' operating expenditure (£2,600,000). The trustees confirmed that there are no material uncertainties regarding the charity's ability to continue as a going concern. Its FY2024 accounts were audited by Price Bailey LLP.
Funders of similar charities
| Funder | Similar charities funded | Amount to them |
|---|---|---|
| DINWOODIE CHARITABLE COMPANY | 2 | £179k |
| MAKERS OF PLAYING CARDS CHARITY | 1 | — |
| THE KIRBY LAING FOUNDATION | 1 | £1.8m |
| GLOBAL HEALTH PARTNERSHIPS | 1 | £596k |
| JAMES PERCY FOUNDATION | 1 | £274k |
| THE BURDETT TRUST FOR NURSING | 1 | £250k |
| THE NUTRITIONAL WELLBEING FOUNDATION | 1 | £126k |
| JOHN ELLERMAN FOUNDATION | 1 | £125k |
Charities like this
- PUBLIC HEALTH COLLABORATION
- COBALT HEALTH
- COELIAC UK
- CICELY SAUNDERS INTERNATIONAL
- ROYAL COLLEGE OF PAEDIATRICS AND CHILD HEALTH
- GENERAL MEDICAL COUNCIL
Side by side with its peers
| Charity | Income | Top pay band | Staff >£60k | Reserves vs policy | Fundraising cost | Going concern |
|---|---|---|---|---|---|---|
| THE COCHRANE COLLABORATION | £10.5m | — | — | above | — | no doubt |
| PUBLIC HEALTH COLLABORATION | £354k | — | 0 | unclear | — | no doubt |
| COBALT HEALTH | £28.2m | — | — | unclear | — | no doubt |
| COELIAC UK | £4.8m | — | — | above | — | no doubt |
| CICELY SAUNDERS INTERNATIONAL | £424k | — | 0 | above | — | no doubt |
| ROYAL COLLEGE OF PAEDIATRICS AND CHILD HEALTH | £21.6m | — | — | below | — | no doubt |